Androgen deprivation therapy for prostate cancer and the risk of autoimmune diseases

Androgen deprivation therapy (ADT) has been a mainstay of treatment for advanced prostate cancer (PCa), but limited studies have been performed to investigate the association between ADT and autoimmune diseases